Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    YXT.com

    MCap

    USD31m

    Last close

    USD5.65

    ▲ 1.12 (24.72%)

    Faraday Future Intelligent Electric

    MCap

    USD12m

    Last close

    USD4.68

    ▲ 0.86 (22.51%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

  • Sectors

    Sectors

  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Herantis Pharma – executive interview

Herantis Pharma – executive interview

Herantis Pharma — 5 videos in collection

More on this equity

Herantis Pharma is a Finland-based clinical-stage biotechnology company focused on developing disease-modifying therapies to stop or reverse the progression of neurodegenerative diseases. Its lead programme is HER-096, a peptide therapeutic, which is currently being assessed in a Phase Ib trial for Parkison’s disease (PD). In this interview, Antti Vuolanto, CEO of Herantis, discusses the progress of HER-096 in the clinic to date, the external validation the company has received through grants and non-dilutive funding, as well as the commercial potential of a disease-modifier for PD. He also covers the key catalysts and milestones that investors should watch out for across the next 12–18 months.

< Previous
Next >

You may also be interested in these:

Healthcare

Herantis Pharma – equity proposition

Healthcare

Herantis Pharma – executive interview
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.